We partnered with Wits Vida, the Vaccine Confidence Fund, and PHRU to study how much, if at all, social media and community influencers can influence and increase uptake of influenza vaccines.
Topic: Drivers of and Barriers to Vaccination
Watch part one of the Global Health Cast’s new series on COVID-19, presented by Prof. Joe Schmitt, Prof. Catherine Weil-Olivier, and the VCP’s very own Dr Emilie Karafillakis.
This article reflects on recent research examining the levels and trends of vaccine confidence over time and across the globe, the drivers influencing confidence, and the role of the COVID-19 pandemic in shaping confidence today.
The VCP – Africa CDC study suggests there could be reasons for this reduction other than the disruption of vaccination programmes during the pandemic.
Polarized debates about COVID-19 vaccination and vaccine mandates for healthcare workers (HCWs) challenge Belgian HCWs ability to discuss Covid-19 vaccine sentiments with peers and patients.
Professor Heidi Larson joins the Edelman Trust Institute’s Justin Blake for the final instalment of our Davos series.
Our third study of COVID-19 vaccine hesitancy among 23,000 respondents in 23 countries, surveyed from 29 June to 10 July 2022 found willingness to accept vaccination at 79.1%, up 5.2% from June 2021.
For Heidi Larson, the founder of the Vaccine Confidence Project, dispelling vaccine hesitancy means building trust — and avoiding the term “anti-vaxxer.
One of my favourite radio guests on “Doctor Radio” on SiriusXM throughout the COVID pandemic has been Heidi Larson, founding director of…
The world’s richest countries are now its most vaccine-hesitant. Can we learn to trust our shots before the next pandemic?
This research aims to develop and evaluate a suite of feasible interventions based on artificial intelligence technologies checking extensions, real-time dashboards, and chatbots – that improve the ability to debunk misinformation, boost self-efficacy in the vaccination decision-making process.
In this large-scale multi-country study, we explored intent to accept a COVID-19 vaccine and the socio-demographic and emotional determinants of uptake for 17 countries.